Dustin Portela, DO
Dermatology · Boise, IDNPI 1588002547
Payments from drug & device makers
Across 524 payments — averaging $314.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dermavant Sciences, Inc.$59K
- AbbVie$23K
- Lilly USA, LLC$20K
- Amgen$19K
- Sanofi$13K
- Bristol Myers Squibb$10K
- plus $20K from 25 others
What the payments were for
- Consulting fees$88,66854%
- Speaking & faculty fees$58,19035%
- Travel & lodging$7,8875%
- Food & beverage$9,1096%
- Education$2890%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dermavant Sciences, Inc. | 21 | $58,697 |
| AbbVie(2 entities) | 148 | $23,448 |
| Lilly USA, LLC | 26 | $20,434 |
| Amgen | 32 | $18,681 |
| Sanofi | 42 | $13,195 |
| Bristol Myers Squibb | 13 | $10,462 |
| Sun Pharmaceutical Industries Inc. | 19 | $9,987 |
| Novartis | 45 | $4,366 |
| Pfizer | 13 | $2,195 |
| Galderma Laboratories, L.p. | 40 | $657 |
| Johnson & Johnson | 36 | $544 |
| E.r. Squibb & Sons, L.L.C. | 11 | $429 |
| UCB, Inc. | 12 | $275 |
| Regeneron Healthcare Solutions, Inc. | 11 | $241 |
| Organon | 11 | $184 |
| Incyte Corporation | 8 | $183 |
| Merz North America, Inc. | 9 | $173 |
| LEO Pharma Inc. | 6 | $130 |
| Acera Surgical, Inc. | 2 | $104 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Arcutis Biotherapeutics, Inc. | 3 | $59 |
| Kerecis Limited | 1 | $54 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $40 |
| Strata Skin Sciences, Inc. | 3 | $34 |
| Mimedx Group, Inc. | 1 | $33 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $29 |
| Boehringer Ingelheim | 1 | $28 |
| Merck | 1 | $18 |
| Prugen, Inc. Pharmaceuticals | 1 | $14 |
| Organogenesis Inc. | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$164,804 in reported general payments places this provider in the 95th percentile of 52 dermatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 16 | $321,636 |
| Humira(Cf) PenAdalimumab | 16 | $166,527 |
| Dupixent PenDupilumab | 37 | $139,948 |
| Cromolyn Sodium | 17 | $10,017 |
| Clobetasol Propionate | 91 | $5,982 |
| Fluorouracil | 37 | $3,785 |
| Tacrolimus | 19 | $3,783 |
| Fluocinonide | 26 | $1,361 |
| Triamcinolone Acetonide | 86 | $1,163 |
| Doxycycline Hyclate | 42 | $996 |
| Ketoconazole | 67 | $774 |
| ValacyclovirValacyclovir Hcl | 32 | $640 |
| Hydroxychloroquine Sulfate | 15 | $531 |
| Clindamycin Phosphate | 17 | $451 |
| Mometasone Furoate | 11 | $249 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Boise
- Steven MingsBoise$82K
- Nicholas BlickenstaffBoise$6K
- Jared ScottBoise$3K
- Heather LayherBoise$2K
- Marnie RirieBoise$208
- Lindie BortonBoise$97
- Jennifer DeblieckBoise$0
- Leon NowierskiBoise$0
- Ryan HarrisMeridian$738K
- Alan OlmsteadTwin Falls$426K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.